Results 11 to 20 of about 1,011,808 (312)
Open Medicine, 2021 Hepatitis A virus immunoglobulin M (HAV-IgM) is often used to diagnose acute hepatitis A virus (HAV) infection serologically. However, false-positive test results can interfere with the diagnosis.
Tan Youwen, Chen Li
doaj +1 more source
‘It’s been a long haul, a big haul, but we’ve made it’: hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysis [PDF]
, 2018 The lived experience of both interferon-based and new interferon-free treatments in patients with hepatitis C virus remains understudied. To explore their journey through hepatitis C virus treatment, we interviewed seven post-transplant patients with ...
Chouliara, Zoe +4 more
core +3 more sources
Scientific Reports, 2023 The novel targeted therapeutics for hepatitis C virus (HCV) in last decade solved most of the clinical needs for this disease. However, despite antiviral therapies resulting in sustained virologic response (SVR), a challenge remains where the stage of ...
Laurent Gole +11 more
doaj +1 more source
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy [PDF]
, 2006 BACKGROUND: The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated.
Ancarani, Fausto +14 more
core +2 more sources
Human Vaccines & Immunotherapeutics, 2020 Hepatitis A is an important public health issue worldwide. Hepatitis A vaccine (HepA) was first licensed in 1992. Both inactivated HepA (HepA-I) and live attenuated HepA (HepA-L) are highly immunogenic and well tolerated, and immune protection postvaccination can persist for at least 20 y.
openaire +3 more sources
Liver Allograft: Its Use in Chronic Active Hepatitis with Macronodular Cirrhosis, Hepatitis B Surface Antigen [PDF]
, 1979 A patient suffering from chronic active hepatitis with macronodular cirrhosis, positive for hepatitis B surface antigen (HBsAg), was treated with an orthotopic liver allograft.
Corman, JL +7 more
core +1 more source
Human Vaccines & Immunotherapeutics, 2019 Hepatitis A is a vaccine-preventable infection caused by the HA virus (HAV) with transitional to intermediate endemicity in China. An inactivated vaccine first licensed in China in 2010 (Avaxim® 80U Pediatric) is indicated for primary and booster ...
Nianmin Shi, Anvar Rasuli, Yaël Thollot
doaj +1 more source
Biomédica: revista del Instituto Nacional de Salud, 2021 Introduction: Enteric viruses have been associated with the production of a variety of diseases transmitted by the fecal-oral route and carried through contaminated food and water.
Raquel Villamizar +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 In most countries of the Middle East and Northern African (MENA) region, a high hepatitis A virus (HAV) endemicity has been documented. Few others, such as Saudi Arabia and Turkey, are transitioning from high to intermediate endemicity.
Selim Badur +5 more
doaj +1 more source
Hepatitis A seroprevalence in Erzurum, Turkey
Annals of Agricultural and Environmental Medicine, 2020 Introduction and objective Hepatitis A Virus (HAV), reportedly the most common cause of acute viral hepatitis in developing countries, infects millions of people worldwide each year.
Ahmet Yilmaz
doaj +1 more source